• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
On the Increased Event Rate of Urinary Tract Infection and Pneumonia in CKD Patients Treated with Roxadustat for Anemia.罗沙司他治疗慢性肾脏病贫血患者时尿路感染和肺炎事件发生率增加的情况
J Am Soc Nephrol. 2021 Jun 1;32(6):1537. doi: 10.1681/ASN.2021020204. Epub 2021 Apr 13.
2
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.罗沙司他（FG-4592）治疗非透析依赖性慢性肾脏病（NDD-CKD）患者贫血的随机安慰剂对照剂量范围及药效学研究。
Nephrol Dial Transplant. 2015 Oct;30(10):1665-73. doi: 10.1093/ndt/gfv302. Epub 2015 Aug 3.
3
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis.罗沙司他治疗慢性肾脏病患者贫血的疗效：一项荟萃分析。
Aging (Albany NY). 2021 Jun 11;13(13):17914-17929. doi: 10.18632/aging.203143.
4
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.罗沙司他治疗未透析的日本慢性肾脏病相关贫血患者的疗效：一项 2 期、随机、双盲、安慰剂对照试验。
Adv Ther. 2019 Jun;36(6):1438-1454. doi: 10.1007/s12325-019-00943-4. Epub 2019 Apr 5.
5
A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat.慢性肾脏病患者贫血管理的新方法：罗沙司他综述
Adv Ther. 2017 Apr;34(4):848-853. doi: 10.1007/s12325-017-0508-9. Epub 2017 Mar 13.
6
The efficacy and economic evaluation of roxadustat treatment for anemia in patients with kidney disease not receiving dialysis.罗沙司他治疗未透析肾病患者贫血的疗效和经济评价。
Expert Rev Pharmacoecon Outcomes Res. 2020 Aug;20(4):411-418. doi: 10.1080/14737167.2020.1747436. Epub 2020 Apr 4.
7
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.日本血液透析慢性肾脏病贫血患者罗沙司他的 3 期、随机、双盲、阳性对照（达贝泊汀α）研究。
J Am Soc Nephrol. 2020 Jul;31(7):1628-1639. doi: 10.1681/ASN.2019060623. Epub 2020 Jun 3.
8
Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open-Label Study.罗沙司他间歇性口服给药治疗腹膜透析慢性肾脏病贫血患者：一项随机、3期、多中心、开放标签研究。
Ther Apher Dial. 2020 Apr;24(2):115-125. doi: 10.1111/1744-9987.12888. Epub 2019 Jul 31.
9
Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients.影响非透析患者罗沙司他与达贝泊汀治疗贫血剂量的因素。
Am J Nephrol. 2021;52(9):702-713. doi: 10.1159/000519043. Epub 2021 Oct 8.
10
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis.一项评估罗沙司他间歇口服给药治疗未接受透析的非透析慢性肾脏病且对红细胞生成刺激剂初治的日本贫血患者的 3 期、多中心、随机、双盲、开放性研究
Nephron. 2020;144(8):372-382. doi: 10.1159/000508100. Epub 2020 Jun 24.

引用本文的文献

1
Efficacy and Safety of Roxadustat in Patients with Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials including 6,518 Patients.罗沙司他治疗慢性肾脏病患者的疗效和安全性：一项包含 6518 例患者的随机对照试验的更新荟萃分析。
Biomed Res Int. 2022 Nov 14;2022:2413176. doi: 10.1155/2022/2413176. eCollection 2022.
2
Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis.罗沙司他治疗慢性肾脏病患者贫血的感染风险：一项系统评价、荟萃分析及试验序贯分析
Front Pharmacol. 2022 Sep 16;13:967532. doi: 10.3389/fphar.2022.967532. eCollection 2022.
3
Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease.缺氧诱导因子稳定剂治疗慢性肾脏病贫血。
Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD013751. doi: 10.1002/14651858.CD013751.pub2.

On the Increased Event Rate of Urinary Tract Infection and Pneumonia in CKD Patients Treated with Roxadustat for Anemia.

作者信息

Eleftheriadis Theodoros, Pissas Georgios, Liakopoulos Vassilios, Stefanidis Ioannis

机构信息

Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa, Greece.

出版信息

J Am Soc Nephrol. 2021 Jun 1;32(6):1537. doi: 10.1681/ASN.2021020204. Epub 2021 Apr 13.

DOI:10.1681/ASN.2021020204
PMID:33849917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8259647/
Abstract
摘要